15 . November , 2018 - Thursday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Dexamethasone

Big Image Pronouncation: (DEX-uh-METH-uh-sone)
Class: Topical corticosteroid, Glucocorticoid, Corticosteroid

Trade Names:
- Tablets 0.5 mg
- Tablets 0.75 mg
- Tablets 1 mg
- Tablets 1.5 mg
- Tablets 2 mg
- Tablets 4 mg
- Tablets 6 mg
- Elixir 0.5 mg per 5 mL
- Solution, oral 0.5 mg per 5 mL

Trade Names:
Dexamethasone Intensol
- Concentrate, oral 1 mg/mL

Trade Names:
- Suspension, ophthalmic 0.1%

Dexamethasone Sodium Phosphate

Trade Names:
Dexamethasone Sodium Phosphate
- Injection 4 mg/mL
- Injection 10 mg/mL

Trade Names:
- Solution, ophthalmic 0.1%

PMS-Dexamethasone (Canada)
ratio-Dexamethasone (Canada)

Mechanism of Action


Synthetic long-acting glucocorticoid that depresses formation, release and activity of endogenous mediators of inflammation including prostaglandins, kinins, histamine, liposomal enzymes and complement system. Also modifies body's immune response.



Metabolized in the liver by CYP3A4.


The t ½ 1.8 to 3.5 h.


Rapid (injection).


Short (injection).

Indications and Usage

Testing of adrenal cortical hyperfunction; management of allergic and inflammatory ophthalmic processes, allergic states, cerebral edema associated with primary or metastatic brain tumor, collagen diseases, craniotomy or head injury, dermatologic diseases, edematous states (caused by nephrotic syndrome), GI diseases, hematologic disorders, multiple sclerosis, neoplastic diseases, primary or secondary adrenal cortex insufficiency, respiratory diseases, rheumatic disorders, trichinosis with neurologic or myocardial involvement, tuberculous meningitis.

Intralesional administration

Treatment for such conditions as alopecia areata, discoid lupus erythematosus, keloids, psoriatic plaques.

Intra-articular or soft tissue administration

Short-term adjunctive treatment for such conditions as synovitis of osteoarthritis, rheumatoid arthritis, acute gouty arthritis, posttraumatic osteoarthritis.


Treatment of steroid-responsive inflammatory conditions of palpebral and bulbar conjunctiva, lid, cornea, and anterior segment of globe.


Systemic fungal infections; IM use in idiopathic thrombocytopenic purpura; administration of live virus vaccines; topical monotherapy in primary bacterial infections; intranasal use in untreated localized infections involving nasal mucosa; ophthalmic use in acute superficial herpes simplex keratitis, fungal diseases of ocular structures, vaccinia, varicella, and ocular tuberculosis.

Dosage and Administration

All dosages shown are for adults unless indicated otherwise.

Initial dose

PO 0.75 to 9 mg/day.

Suppression Tests Cushing syndrome

PO 1 mg at 11 PM or 0.5 mg every 6 h for 48 h.

To distinguish Cushing syndrome-caused pituitary ACTH excess from other causes

PO 2 mg every 6 h for 48 h.

Acute Mountain Sickness

PO 4 mg every 6 h.


PO 16 to 20 mg.

Diagnosis of Depression

PO 1 mg.


PO 0.5 to 1 mg/day.

Ophthalmic solution

Instill 1 to 2 drops into conjunctival sac 4 to 6 times daily.

Dexamethasone Sodium Phosphate

IV/IM 0.5 to 9 mg/day.

Cerebral Edema

IV 10 mg, then IM 4 mg every 6 h until max response.

Brain Tumors

IV/IM 2 mg 2 to 3 times daily.

Unresponsive shock

IV 1 to 6 mg/kg as single injection; or 40 mg followed by repeated IV injections every 2 to 6 h.

Bacterial meningitis

IV 0.15 mg/kg every 6 h.

Bronchopulmonary dysplasia in preterm infants

IV 0.5 mg/kg.

Intra-Articular, Intralesional, or Soft Tissue

Large joints 2 to 4 mg; small joints 0.8 to 1 mg; bursae 2 to 3 mg; tendon sheaths 0.4 to 1 mg; soft tissue infiltration 2 to 6 mg; ganglia 1 to 2 mg.

Ophthalmic solution

Instill 1 to 2 drops into conjunctival sac every 1 h during day and every 2 h during night.


Refer to package insert for directions on how to store particular form of dexamethasone.

Drug Interactions


May decrease dexamethasone-induced adrenal suppression.


May antagonize anticholinesterase effects in myasthenia gravis.

Anticoagulants, oral

May alter anticoagulant dose requirements.


May decrease effects of dexamethasone.


May increase Cl and decrease therapeutic efficacy of dexamethasone.


May increase Cl and decrease therapeutic efficacy of dexamethasone.


May reduce serum levels and efficacy of salicylates.


May increase dexamethasone effects.

Laboratory Test Interactions

May cause increased urine glucose and serum cholesterol; decreased serum levels of potassium, T 3 and T 4 ; decreased uptake of thyroid 131 I; false-negative nitroblue-tetrazolium test; altered brain scan results; suppression of skin test reactions.

Adverse Reactions


Cardiac arrhythmias or ECG changes, CHF, hypertension, myocardial rupture, necrotizing angiitis, syncopal episodes, thromboembolism or fat embolism, thrombophlebitis.


Headache, increased intracranial pressure with papilledema (pseudotumor cerebri), neuritis, paresthesias, psychosis, seizures, vertigo.


Acneiform eruptions, allergic contact dermatitis, allergic dermatitis, angioneurotic edema, burning, cracking and tightening of skin, dryness, erythema, erythema, folliculitis, hirsutism, hyperpigmentation or hypopigmentation, hypertrichosis, pruritus, impaired wound healing, irritation, itching, lupus erythematosus-like lesions, miliaria, perineal irritation, perioral dermatitis, secondary infections, skin atrophy, stinging, striae, subcutaneous fat atrophy, striae, telangiectasia (topical), thin fragile skin, petechiae and ecchymoses, urticaria.


Posterior subcapsular cataracts; increased IOP; glaucoma; exophthalmos. Dry mouth; throat irritation; hoarseness; dysphonia; coughing (oral inhalation). Nasal irritation; burning; stinging; dryness; epistaxis or bloody mucus; rebound congestion; sneezing, rhinorrhea; anosmia; loss of sense of taste; throat discomfort (intranasal). Glaucoma with optic nerve damage; visual acuity and field defects; posterior subcapsular cataract formation; secondary ocular infections; transient stinging or burning (ophthalmic).


Abdominal distension, bowel perforation, increased appetite and weight gain, nausea, pancreatitis, peptic ulcer with perforation and hemorrhage, ulcerative esophagitis, vomiting.


Increased or decreased number and motility of spermatozoa.




Hypocalcemia, hypokalemia, hypokalemic alkalosis, metabolic alkalosis, sodium and fluid retention.


Wheezing (oral inhalation).


Aggravation or masking of infections, endocrine abnormalities (eg, menstrual irregularities, cushingoid state, growth suppression in children sweating, decreased carbohydrate tolerance, hyperglycemia, glycosuria, increased insulin or sulfonylurea requirements in diabetics, anaphylactoid or hypersensitivity reactions), facial flushing (intra-articular), fatigue, hypersensitivity, infection, insomnia, leukocytosis, malaise, musculoskeletal effects (eg, weakness, myopathy, muscle mass loss, osteoporosis, spontaneous fractures), osteonecrosis, postinjection flare, skin atrophy, tendon rupture, topical use may theoretically produce adverse reactions seen with systemic use because of absorption.



Pregnancy category undetermined (systemic use); Category C (topical uses).


Excreted in breast milk.


May be more susceptible to adverse reactions from topical use than are adults. Observe growth and development of infants and children on prolonged therapy.


May require lower doses.

Renal Function

Use cautiously; monitor renal function.

Sulfite Sensitivity

Some products may contain sodium bisulfite, which may cause allergic-type reactions in some individuals.

Adrenal suppression

Prolonged therapy may lead to hypothalamic-pituitary-adrenal suppression.

Fluid and electrolyte balance

Can cause elevated BP, salt and water retention, and increased potassium and calcium excretion. Dietary salt restriction and potassium supplementation may be needed.


May be harmful in chronic active hepatitis positive for hepatitis B surface antigen.


May mask signs of infection. May decrease host-defense mechanisms to prevent dissemination of infection.

Ocular effects

Use systemically with caution in ocular herpes simplex because of possible corneal perforation.

Ophthalmic use

Prolonged use may result in glaucoma or other complications.

Peptic ulcer

May contribute to peptic ulceration, especially in large doses.


Increased dosage of rapidly acting corticosteroid may be needed before, during and after stressful situations.


Abrupt discontinuation may result in adrenal insufficiency. Discontinue gradually.



Acne, anorexia, arthralgia, central obesity, diabetes, dizziness, dyspnea, ecchymoses, electrolyte and fluid imbalance (chronic cushingoid changes), fainting, fever, hirsutism, hyperlipidemia, hypertension, hypoglycemia (acute overdose), infection, malaise, moonface, myalgia, myopathy, nausea, orthostatic hypotension, osteoporosis, peptic ulcer, sexual dysfunction, skin desquamation, striae.

Patient Information

  • Caution patient that stopping drug abruptly is dangerous and may cause adrenal insufficiency.
  • Explain rationale for tapering off medication when that time comes.
  • Teach patient or family procedures for correctly administering specific form of drug (eg, ophthalmic).
  • Caution patient against receiving immunizations while drug is being taken.
  • Advise patient on long-term therapy to carry medication identification card or to wear bracelet. In case of emergency, this information is important for treatment.
  • Instruct patient to avoid people with infections, particularly respiratory.
  • Teach patient to take oral forms with meals or snacks if GI irritation occurs.
  • Review guidelines for missed doses of particular product with patient.
  • Teach patient on long-term therapy how to keep a weight record.
  • Instruct patient to inform other health care providers if taking a steroid.
  • Review signs of infection and remind patient that fever, swelling, and redness may be masked in infection.
  • Review possible adverse reactions of dexamethasone with patient and to report these to health care provider.

Recent Drug Updates at DrugIndexOnline:

Black Draught Black Draught
Generic Name: senna (SEH nah) Brand Names: Black Draught, Dosaflex, Dr Caldwell Laxative, Ex-Lax Chocolated, Ex-Lax Gentle Nature, Ex-Lax Maximum Relief Formula, Ex-Lax Regular Strength Pills, Fletchers Castoria, Gentlax, Innerclean, Sennalax, Senokot, Senokot Child, Senokot Extra, Senola more...

Calmylin Expectorant Calmylin Expectorant
Some commonly used brand names are: In the U.S.— Anti-Tuss Breonesin Diabetic Tussin EX Fenesin Gee-Gee Genatuss Glycotuss Glytuss Guiatuss Halotussin Humibid L.A. Humibid Sprinkle Hytuss Hytuss-2X Naldecon Senior EX Organidin NR Pneumomist Robitussin Scot-tussin Expectorant Sinumist-SR T more...

Geravine Elixir Geravine Elixir
Generic Name: Vitamins with Lipotropics Elixir and Liquid (VYE-ta-mins/lye-po-TROE-piks) Brand Name: Examples include Geravine and LysiplexGeravine Elixir is used for:Providing vitamins and certain other nutrients as a supplement to the diet. It may also be used for other conditions as determin more...

Hydromorphone Hydromorphone
Generic Name: Hydromorphone Injection (HYE-droe-MOR-fone) Brand Name: DilaudidHydromorphone is used for:Treating severe pain in certain patients. Hydromorphone is an opioid (narcotic) analgesic. It works by binding to certain receptors in the brain and nervous system to reduce pain. Do NOT use more...

Micardis HCT Micardis HCT
Generic Name: hydrochlorothiazide and telmisartan (hye droe klor oh THYE a zide and TELL mih sar tan) Brand Names: Micardis HCT What is Micardis HCT (hydrochlorothiazide and telmisartan)? Hydrochlorothiazide is a thiazide diuretic (water pill) that helps prevent your body from absorbing more...

Ovidrel Ovidrel
Some commonly used brand names are: In the U.S.— Ovidrel Category Infertility therapy gonadotropin Description Choriogonadotropin alfa (KOR-ee-o-goe-nad-oh-troe-pin AL-fa) is a substance used to help women become pregnant. It is usually given to women after they have been treated more...

Perphenazine Amitriptyline Perphenazine Amitriptyline
Generic Name: perphenazine and amitriptyline hydrochloride Dosage Form: Tablets, usp 2 mg/10 mg, 2 mg/25 mg, 4 mg/10 mg, 4 mg/25 mg and 4 mg/50 mg Rx only Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) more...

Prevacid NapraPAC Prevacid NapraPAC
Generic name: Brand names: Prevacid NapraPAC Why is Prevacid NapraPAC prescribed? Prevacid NapraPAC is prescribed to relieve arthritis symptoms in people who also have a history of stomach ulcers. It's used to treat pain caused by osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis more...